Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Gorodezki, David [VerfasserIn]   i
 Chiang, Jason [VerfasserIn]   i
 Viaene, Angela N. [VerfasserIn]   i
 Sievers, Philipp [VerfasserIn]   i
 Schmid, Simone [VerfasserIn]   i
 Holzer, Ursula [VerfasserIn]   i
 Paulsen, Frank [VerfasserIn]   i
 Schuhmann, Martin U. [VerfasserIn]   i
 Witt, Olaf [VerfasserIn]   i
 Schittenhelm, Jens [VerfasserIn]   i
 Ebinger, Martin [VerfasserIn]   i
Titel:A multi-institutional series of a novel, recurrent TRIM24::MET fusion-driven infant-type hemispheric glioma reveals significant clinico-pathological heterogeneity
Verf.angabe:David Gorodezki, Jason Chiang, Angela N. Viaene, Philipp Sievers, Simone Schmid, Ursula Holzer, Frank Paulsen, Martin U. Schuhmann, Olaf Witt, Jens Schittenhelm and Martin Ebinger
E-Jahr:2024
Jahr:21 June 2024
Umfang:10 S.
Illustrationen:Illustrationen
Fussnoten:Gesehen am 20.02.2025
Titel Quelle:Enthalten in: Acta Neuropathologica Communications
Ort Quelle:London : Biomed Central, 2013
Jahr Quelle:2024
Band/Heft Quelle:12(2024) vom: Juni, Artikel-ID 101, Seite 1-10
ISSN Quelle:2051-5960
Abstract:Within the past decade, incremental integration of molecular characteristics into the classification of central nervous system neoplasms increasingly facilitated precise diagnosis and advanced stratification, beyond potentially providing the foundation for advanced targeted therapies. We report a series of three cases of infant-type hemispheric glioma (IHG) involving three infants diagnosed with neuroepithelial tumors of the cerebral hemispheres harboring a novel, recurrent TRIM24::MET fusion. Histopathology showed glial tumors with either low-grade or high-grade characteristics, while molecular characterization found an additional homozygous CDKN2A/B deletion in two cases. Two patients showed leptomeningeal dissemination, while multiple supra- and infratentorial tumor manifestations were found in one case. Following subtotal resection (two cases) and biopsy (one case), treatment intensity of adjuvant chemotherapy regimens did not reflect in the progression patterns within the reported cases. Two patients showed progression after first-line treatment, of which one patient died not responding to tyrosine kinase inhibitor cabozantinib. As the detection of a recurrent TRIM24::MET fusion expands the spectrum of renowned driving fusion genes in IHG, this comparative illustration may indicate a distinct clinico-pathological heterogeneity of tumors bearing this driver alteration. Upfront clinical trials of IHG promoting further characterization and the implementation of individualized therapies involving receptor tyrosine kinase inhibition are required.
DOI:doi:10.1186/s40478-024-01817-9
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.1186/s40478-024-01817-9
 DOI: https://doi.org/10.1186/s40478-024-01817-9
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Brain Neoplasms
 Carrier Proteins
 Female
 Glioma
 Humans
 Infant
 Infant-type hemispheric glioma
 Male
 MET fusion
 Oncogene Proteins, Fusion
 Proto-Oncogene Proteins c-met
 TRIM24::MET fusion
K10plus-PPN:1917691955
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69306546   QR-Code
zum Seitenanfang